889 related articles for article (PubMed ID: 11691681)
21. The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical use.
Ruiz Diaz JC; Frenkel D; Aronow WS
Expert Opin Drug Saf; 2020 May; 19(5):559-564. PubMed ID: 32189527
[No Abstract] [Full Text] [Related]
22. Long QTc interval and torsade de pointes caused by fluconazole.
Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
[TBL] [Abstract][Full Text] [Related]
23. Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.
Czekalla J; Kollack-Walker S; Beasley CM
J Clin Psychiatry; 2001; 62 Suppl 2():35-40. PubMed ID: 11232751
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
25. Psychiatric medications and sudden cardiac death: putting the risk in perspective.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):23-5. PubMed ID: 25654571
[TBL] [Abstract][Full Text] [Related]
26. Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany.
Elsayed M; Abdel-Kahaar E; Gahr M; Connemann BJ; Denkinger M; Schönfeldt-Lecuona C
Eur J Clin Pharmacol; 2021 May; 77(5):767-775. PubMed ID: 33230596
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
[TBL] [Abstract][Full Text] [Related]
28. The comparative cardiac effects of haloperidol and quetiapine: parsing a review.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2014 Jun; 52(6):23-6. PubMed ID: 24967672
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Safety Margin of an Antipsychotic Drug Haloperidol for Torsade de Pointes Using the Chronic Atrioventricular Block Dogs.
Izumi-Nakaseko H; Nakamura Y; Cao X; Wada T; Ando K; Sugiyama A
Cardiovasc Toxicol; 2017 Jul; 17(3):319-325. PubMed ID: 27738880
[TBL] [Abstract][Full Text] [Related]
30. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
31. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
Kecskeméti V
Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
[TBL] [Abstract][Full Text] [Related]
32. New Generation Antipsychotic Drugs and QTc Interval Prolongation.
Vieweg WV
Prim Care Companion J Clin Psychiatry; 2003 Oct; 5(5):205-215. PubMed ID: 15213787
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
34. Sudden cardiac death secondary to antidepressant and antipsychotic drugs.
Sicouri S; Antzelevitch C
Expert Opin Drug Saf; 2008 Mar; 7(2):181-94. PubMed ID: 18324881
[TBL] [Abstract][Full Text] [Related]
35. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
36. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
[TBL] [Abstract][Full Text] [Related]
37. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach.
Polcwiartek C; Sneider B; Graff C; Taylor D; Meyer J; Kanters JK; Nielsen J
Psychopharmacology (Berl); 2015 Sep; 232(18):3297-308. PubMed ID: 26231497
[TBL] [Abstract][Full Text] [Related]
38. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
39. Sulpiride induced torsade de pointes.
Huang BH; Hsia CP; Chen CY
Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
[TBL] [Abstract][Full Text] [Related]
40. [Lengthening of QT interval by antipsychotic drugs].
Haverkamp W; Deuschle M
Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]